SOMATROPIN

somatropin 6 mg/1.03 mL injection, 1.03 mL cartridge

SOMATROPIN (13712Q)

somatropin 6 mg/1.03 mL injection, 1.03 mL cartridge
13712Q
Body System:
Manner of administration:Injection
S100 Growth Hormone Programme
Authority Required

Restriction

Indication: Severe growth hormone deficiency
Treatment phase: Initial treatment of late onset growth hormone deficiency

Restriction

Indication: Severe growth hormone deficiency
Treatment phase: Continuing treatment in a person with a mature skeleton or aged 18 years or older

Restriction

Indication: Severe growth hormone deficiency
Treatment phase: Initial treatment of childhood onset growth hormone deficiency in a patient who has received PBS-subsidised treatment as a child

Restriction

Indication: Severe growth hormone deficiency
Treatment phase: Initial treatment of childhood onset growth hormone deficiency in a patient who has received non-PBS subsidised treatment as a child
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 1 Max qty units: 1 # of repeats: 5 DPMQ: $197.96 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
Saizen